User:Beach4444/Nariman Mehta

This is to establish a talk page for "Nariman Mehta".

The purpose is to obtain help in creating a link to the "Nariman Mehta" website or to create a new article from the website about "Nariman Mehta", so that the reader could read a short bio about the inventor of the drug Wellbutrin.

Can I copy and paste the copy from the website, if I personally authored the site? The personal info on Dr. Mehta came from an interview he gave me. Let it also be noted that Dr. Mehta is my father-inlaw. Any papers or Patents have been verified through the USPO and published papers have been authenticated through a book published through GlaxoSmithKline and presented to Dr. Mehta as a personal copy and as a copy in their library.

I would like someone to assist or help edit this article if possible. I am apparently making numerous errors on my own. Beach4444 (talk) 01:44, 1 September 2009 (UTC)

Nariman B. Mehta was born in Bombay, India April 8, 1920. He began his schooling at the St. Xavier School and College, where he received a B.S. in Chemistry/Physics and a B.A. in English/Economics. Being an exceptional student, Nari was hired to private tutor over 80 students in math, physics, chemistry, and marine engineering. In 1939, he and a fellow student wrote and published “ Textbook of Theoretical and Practical Physics.” In 1947, Nari was invited by Joseph E Seagram & Sons to be a trainee in their research lab and study fermentation and distillation. This was all possible by winning the Tata Scholarship, a grant from Herman Wilkie for exceptional students. From 1949 – 1952, while on a US Navy Fellowship, Mehta earned his Ph.D. and minor in chemical engineering, at Kansas University under Dr. Bill McEwen, working on the synthesis of Emetine. For the next three years, Nari was a Professor of Physical Chemistry at Wilberforce College in Ohio. In 1957, Nari joined the pharmaceutical company, Burroughs Wellcome, Inc., where he worked on neuropsychopharmacological potential drugs. He designed, synthesized and patented a single compound [BW 323U66] Bupropion, an entirely novel class of chemical structure for an antidepressant. In the spring of 1986, the FDA approved it. It was the first drug approved by the FDA for “Cessation of Smoking” [Zyban]. Bupropion has four physiological activates: 1) antidepressants, 2) stop smoking, 3) increase in libido (women), 4) mild weight loss. Today, GlaxoSmithKline has sold over $25B under the name Wellbutrin. Nariman now resides with his 3 children and 4 grandchildren in NC. Beach4444 (talk) 02:15, 1 September 2009 (UTC)